600276 恒瑞医药
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额786,44611,235,3787,422,7537,643,6651,265,265
投资活动产生之现金流量净额(723,746)(2,740,502)(1,911,986)1,222,315390,289
筹资活动产生之现金流量净额(185,717)7,781,707(1,550,590)(3,144,426)(318,770)
汇率变动对现金及现金等价物的影响(349,702)(360,133)7,40112,53380,497
现金及现金等价物净增加/(减少)(472,719)15,916,4513,967,5785,734,0871,417,281
期初现金及现金等价物余额40,155,55324,239,10220,271,52414,537,43713,120,156
期末现金及现金等价物余额39,682,83440,155,55324,239,10220,271,52414,537,437